Indolentcutaneous CD8+ lymphoidproliferation is a recently described rare entity among cutaneous T-cell lymphomas that typically presents with solitary skin lesions on the face or at acral sites.
Histology of indolent cutaneous CD8+ lymphoid proliferation
Histologically, indolent CD8+ lymphoid proliferations are characterised by a dense dermalinfiltrate of non-epidermotropic, medium sized pleomorphiclymphocytes. These form a dense mass in the dermis and may involve subcutaneous tissues (figures 1-5).
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Special studies for indolent cutaneous CD8+ lymphoid proliferation
The T-cells stain with CD3 and CD8 (figure 6). There is minimal staining with CD4. Other T-cell markers are variably expressed. CD68 is positive in most cases.
T-cell receptorgene rearrangement may be demonstrated with rearrangement studies.
Differential diagnosis of indolent cutaneous CD8+ lymphoid proliferation
Aggressive cutaneous CD8 positive lymphoma – These do not usually present as single tumours/plaques. CD68 is typically negative and is thought to be a helpful distinguishing feature.
Mycosis fungoides – Clinical presentation is key in distinguishing this entity from tumour stage mycosis fungoides. If the patient has a past history of mycosis fungoides, caution should be take in diagnosing cutaneous small-medium pleomorphic T-cell lymphoma.
T-cell pseudolymphoma – May be similar and many cases may have been called pseudolymphoma in the past. Immunohistochemical studies and T-cell gene rearrangement studies may be helpful to illustrate a clonal population.
Cutaneous small–medium pleomorphic T-cell lymphoma – This entity is composed predominantly of CD4 positive cells. Some authors question whether this is a related entity (given similar benign presentation and course).
References
Wobser M, et al. CD68 expression is a discriminative feature of indolent cutaneous CD8-positive lymphoid proliferation and distinguishes this lymphoma subtype from other CD8-positive cutaneous lymphomas. Br J Dermatol. 2014 Dec 18. doi: 10.1111/bjd.13628. PubMed